Ausgabe 1/2021
Inhalt (39 Artikel)
CT protocol optimisation in PET/CT: what we learn from a systematic review
V. Bertolini, V. Trojani, M. Bertolini
To what extent has the reorganization of nuclear medicine activities during the COVID-19 pandemic fulfilled medical ethics?
Sandra Gonzalez, David Taïeb, Eric Guedj, Pierre Le Coz, Serge Cammilleri
Radiological protection and biological COVID-19 protection in the nuclear medicine department
Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hirofumi Fujii
Augmented deep learning model for improved quantitative accuracy of MR-based PET attenuation correction in PSMA PET-MRI prostate imaging
Andrii Pozaruk, Kamlesh Pawar, Shenpeng Li, Alexandra Carey, Jeremy Cheng, Viswanath P. Sudarshan, Marian Cholewa, Jeremy Grummet, Zhaolin Chen, Gary Egan
Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
Antonia Dimitrakopoulou-Strauss, Leyun Pan, Christos Sachpekidis
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis
A. R. Coda, S. Anzilotti, F. Boscia, A. Greco, M. Panico, S. Gargiulo, M. Gramanzini, A. Zannetti, S. Albanese, G. Pignataro, L. Annunziato, M. Salvatore, A. Brunetti, P. De Berardinis, Mario Quarantelli, G. Palma, Sabina Pappatà
Imaging assisted evaluation of antitumor efficacy of a new histone deacetylase inhibitor in the castration-resistant prostate cancer
Zude Chen, Xiashuang Wang, Xiaoshuang Yang, Yulong Xu, Yu Yang, Hao Wang, Tao Li, Ping Bai, Gengyang Yuan, Huabiao Chen, Jing Yang, Stephanie A. Fiedler, Robin Striar, Daniela R. Bernales, Robert E. Koegel, Qi Cao, Chongzhao Ran, Bo Xiang, Hong Li, Changning Wang
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
Mark Konijnenberg, Ken Herrmann, Carsten Kobe, Frederik Verburg, Cecilia Hindorf, Roland Hustinx, Michael Lassmann
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
Haojun Chen, Liang Zhao, Dan Ruan, Yizhen Pang, Bing Hao, Yaqing Dai, Xiurong Wu, Wei Guo, Chunlei Fan, Jingxun Wu, Weipeng Huang, Qin Lin, Long Sun, Hua Wu
Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
M Celli, U De Giorgi, P Caroli, V Di Iorio, L Fantini, V Rossetti, F Foca, S Nicolini, M Giganti, G Paganelli, F Matteucci
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang-Keun Woo, Kyo Chul Lee, Joo Hyun Kang, Hee Seup Kil, Chansoo Park, Dae Yoon Chi, Jongwook Park, Kanghyon Song, Sang Moo Lim
Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapy
Fadi Khreish, Niklas Kochems, Florian Rosar, Amir Sabet, Martin Ries, Stephan Maus, Matthias Saar, Mark Bartholomä, Samer Ezziddin
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)
Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P. Baum, Robert Seifert, Katharina Kessel, Martin Bögemann, Harshad R Kulkarni, Jingjing Zhang, Carolin Gerke, Rolf Fimmers, Clemens Kratochwil, Hendrik Rathke, Harun Ilhan, Johanna Maffey-Steffan, Mike Sathekge, Levent Kabasakal, Francisco Osvaldo Garcia-Perez, Kalevi Kairemo, Masha Maharaj, Diana Paez, Irene Virgolini
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients
Christian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica, Anna Svirydenka, Clemens Decristoforo, Gianpaolo di Santo, Elisabeth von Guggenberg, Wolfgang Horninger, Irene Johanna Virgolini
A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases
Ismaheel O. Lawal, Kgomotso M. G. Mokoala, Johncy Mahapane, Janke Kleyhans, Marian Meckel, Mariza Vorster, Thomas Ebenhan, Frank Rösch, Mike M. Sathekge
Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
Stefan A. Koerber, Katharina Sprute, Clemens Kratochwil, Erik Winter, Matthias F. Haefner, Sonja Katayama, Ingmar Schlampp, Klaus Herfarth, Klaus Kopka, Ali Afshar-Oromieh, Stefanie Zschaebitz, Tim Holland-Letz, Peter L. Choyke, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus, Frederik L. Giesel
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study
Giovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, Ilaria Grassi, Toni Ibrahim, Elena Amadori, Valentina Di Iorio, Manuela Monti, Emanuela Scarpi, Alberto Bongiovanni, Mattia Altini, Luca Urso, Corrado Cittanti, Federica Matteucci, Stefano Severi
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
Nina Zhou, Chang Liu, Xiaoyi Guo, Yuping Xu, Jifang Gong, Changsong Qi, Xiaotian Zhang, Min Yang, Hua Zhu, Lin Shen, Zhi Yang
Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer
Sophie E. Vollenbrock, Francine E. M. Voncken, Doenja M. J. Lambregts, Monique Maas, Maarten L. Donswijk, Erik Vegt, Leon C. ter Beek, Jolanda M. van Dieren, Johanna W. van Sandick, Berthe M. P. Aleman, Regina G. H. Beets-Tan, Annemarieke Bartels-Rutten
Diagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients
Marcelo A. Queiroz, Cinthia D. Ortega, Felipe R. Ferreira, Sergio C. Nahas, Giovanni G. Cerri, Carlos A. Buchpiguel
Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules
Ximin Shi, Haiqun Xing, Xiaobo Yang, Fang Li, Shaobo Yao, Hui Zhang, Haitao Zhao, Marcus Hacker, Li Huo, Xiang Li
Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT
Lamiaa Zidan, Amir Iravani, Grace Kong, Tim Akhurst, Michael Michael, Rodney J Hicks
Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
Pei Nie, Guangjie Yang, Ning Wang, Lei Yan, Wenjie Miao, Yanli Duan, Yanli Wang, Aidi Gong, Yujun Zhao, Jie Wu, Chuantao Zhang, Maolong Wang, Jingjing Cui, Mingming Yu, Dacheng Li, Yanqin Sun, Yangyang Wang, Zhenguang Wang
Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis
Yujing Hu, Xinming Zhao, Jianyuan Zhang, Jingya Han, Meng Dai
The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis
D. ten Hove, G. Treglia, R. H. J. A. Slart, K. Damman, M. Wouthuyzen-Bakker, D. F. Postma, O. Gheysens, R. J. H. Borra, G. Mecozzi, P. P. van Geel, B. Sinha, A. W. J. M. Glaudemans
The use of a visual 4-point scoring scale improves the yield of 18F-FDG PET-CT imaging in the diagnosis of renal and hepatic cyst infection in patients with autosomal dominant polycystic kidney disease
Marie F. Neuville, Pierre Lovinfosse, Alexandre Jadoul, Marie Thys, Laurence Seidel, Roland Hustinx, François Jouret
COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome
Matthieu Dietz, Gilles Chironi, Yann-Erick Claessens, Ryan Lukas Farhad, Isabelle Rouquette, Benjamin Serrano, Valérie Nataf, Florent Hugonnet, Benoît Paulmier, Frédéric Berthier, Olivia Keita-Perse, Francesco Giammarile, Christophe Perrin, Marc Faraggi, C. Fissore-Magdelein, S. Gabriel-Solean, B. Dahmani, I. Riss, P. Sorlin, V. Dupasquier, A. Pathak, C. Dugourd, M. Nicolai, N. Rijo, N. Beau, X. Magdelein, F. Olyve, S. Chaillou-Orpitz, J. Lépine, M. Lorillou, C. Maincent, S. Bertrand, P. Brunner, C. Dittlot, F. Fuerxer, M. Liberatore, G. Armando, M. Bouregba, J. Catineau, P. Garcia, D. Tran
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown
Richard Halsey, Dimitrios Priftakis, Strachan Mackenzie, Simon Wan, Laura M. Davis, David Lilburn, Andrew Thornton, Nikolaos Papathanasiou, Gopinath Gnanasegaran, Jamshed Bomanji
CT abnormalities evocative of lung infection are associated with lower 18F-FDG uptake in confirmed COVID-19 patients
Achraf Bahloul, Caroline Boursier, Hélène Jeulin, Laëtitia Imbert, Damien Mandry, Gilles Karcher, Pierre-Yves Marie, Antoine Verger
Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
Amandine Pallardy, Caroline Rousseau, Catherine Labbe, Renan Liberge, Caroline Bodet-Milin, Françoise Kraeber-Bodere, Vincent Fleury
Efficacy of delayed 18F-FDG hybrid PET/MRI for epileptic focus identification: a prospective cohort study
Fang Liu, Weiwei Ruan, Xuejun Deng, Yangmeihui Song, Wenyu Song, Fan Hu, Jinxia Guo, Xiaoli Lan
Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study
Bernard J. Hanseeuw, Vincent Malotaux, Laurence Dricot, Lisa Quenon, Yves Sznajer, Jiri Cerman, John L. Woodard, Christopher Buckley, Gill Farrar, Adrian Ivanoiu, Renaud Lhommel
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT
Hendrik Rathke, Frank Bruchertseifer, Clemens Kratochwil, Hanno Keller, Frederik L. Giesel, Christos Apostolidis, Uwe Haberkorn, Alfred Morgenstern
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour
Elin Pauwels, Sofie Celen, Mathilde Vandamme, William Leysen, Kristof Baete, Oliver Bechter, Marie Bex, Kim Serdons, Koen Van Laere, Guy Bormans, Christophe M. Deroose
[68Ga]Ga-DOTA-TOC PET/CT fused to MRI in post-operative evaluation of olfactory groove meningioma: a case on millimetric remnants
B. Salgues, T. Graillon, E. Guedj
18F-FDG PET/CT of multiple cavitating pulmonary squamous cell carcinoma
Weilong Li, Zhaowei Meng
Application of 18F-FDG PET/CT in necrobiotic xanthogranuloma involving multiple organs
JiaLe Hou, TingTing Long, Shuo Hu
Gallbladder malakoplakia masquerading as malignant primary on 18F-FDG PET/CT
Akshay Sharad Bedmutha, Archi Agrawal, Ritesh R. Suthar, Tushar Agrawal, Nilendu Purandare, Sneha Shah, Ameya Puranik, Rajiv Kumar, V. Rangarajan
Correction to: Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
Pei Nie, Guangjie Yang, Ning Wang, Lei Yan, Wenjie Miao, Yanli Duan, Yanli Wang, Aidi Gong, Yujun Zhao, Jie Wu, Chuantao Zhang, Maolong Wang, Jingjing Cui, Mingming Yu, Dacheng Li, Yanqin Sun, Yangyang Wang, Zhenguang Wang